| Dr Scott Forrester Lindsey, MD | |
|
310 S. Macdill Ave., Suite 201, Tampa, FL 33609 | |
| (813) 609-3810 | |
| (813) 559-1846 |
| Full Name | Dr Scott Forrester Lindsey |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 310 S. Macdill Ave., Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013317460 | NPI | - | NPPES |
| 110178400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | ME136463 (Florida) | Primary |
| 207N00000X | Dermatology | ME136463 (Florida) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Palm Harbor Dermatology Pa | 4789758558 | 30 |
News Archive
The District of Columbia Patients' Cooperative (DCPC), a non-profit, medical cannabis organization registered in the District of Columbia, has submitted comments to the Office of the DC Attorney General addressing numerous issues on proposed regulations announced 45 days ago.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Investigators have assessed the prevalence of treatable traits in severe asthma and have determined which specific traits are predictive of future asthma attacks.
United States hospitals continue to implement palliative care programs at a rapid pace, according to a new analysis released today by the Center to Advance Palliative Care. Palliative care programs are widely regarded to improve the quality of care of serious and chronic illness.
› Verified 4 days ago
| Entity Name | Palm Harbor Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497927016 PECOS PAC ID: 4789758558 Enrollment ID: O20080729000233 |
News Archive
The District of Columbia Patients' Cooperative (DCPC), a non-profit, medical cannabis organization registered in the District of Columbia, has submitted comments to the Office of the DC Attorney General addressing numerous issues on proposed regulations announced 45 days ago.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Investigators have assessed the prevalence of treatable traits in severe asthma and have determined which specific traits are predictive of future asthma attacks.
United States hospitals continue to implement palliative care programs at a rapid pace, according to a new analysis released today by the Center to Advance Palliative Care. Palliative care programs are widely regarded to improve the quality of care of serious and chronic illness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Forrester Lindsey, MD 4919 Memorial Hwy Ste 150, Tampa, FL 33634-7516 Ph: (813) 333-1512 | Dr Scott Forrester Lindsey, MD 310 S. Macdill Ave., Suite 201, Tampa, FL 33609 Ph: (813) 609-3810 |
News Archive
The District of Columbia Patients' Cooperative (DCPC), a non-profit, medical cannabis organization registered in the District of Columbia, has submitted comments to the Office of the DC Attorney General addressing numerous issues on proposed regulations announced 45 days ago.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Investigators have assessed the prevalence of treatable traits in severe asthma and have determined which specific traits are predictive of future asthma attacks.
United States hospitals continue to implement palliative care programs at a rapid pace, according to a new analysis released today by the Center to Advance Palliative Care. Palliative care programs are widely regarded to improve the quality of care of serious and chronic illness.
› Verified 4 days ago
Dr. Alan M Freedman, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4412 W Osborne Ave, Tampa, FL 33614 Phone: 813-914-9100 Fax: 239-278-1159 | |
Philip Shenefelt, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 12901 Bruce B Downs Blvd, Mdc 79, Tampa, FL 33612 Phone: 813-974-2920 | |
Dr. Henry E Wiley Iii, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1425 S Howard Ave, Tampa, FL 33606 Phone: 813-253-2635 Fax: 813-254-7142 | |
Ferwa Mohammed, PA-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1208 E Kennedy Blvd Ste 221, Tampa, FL 33602 Phone: 813-590-6868 | |
Dr. Salma Z Pothiawala, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15310 Amberly Dr, Suite 150, Tampa, FL 33647 Phone: 813-978-8888 Fax: 813-972-8974 | |
Brianna Castillo, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 11601 Sheldon Rd, Tampa, FL 33626 Phone: 813-324-6630 Fax: 813-926-1500 |